Richard Close
Stock Analyst at Canaccord Genuity
(1.28)
# 1,607
Out of 4,667 analysts
126
Total ratings
31.18%
Success rate
-11.22%
Average return
Main Sectors:
Stocks Rated by Richard Close
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PGNY Progyny | Maintains: Hold | $18 → $17 | $13.98 | +21.60% | 5 | Nov 13, 2024 | |
| DOCS Doximity | Downgrades: Hold | $40 → $60 | $49.90 | +20.24% | 8 | Nov 13, 2024 | |
| WAY Waystar Holding | Maintains: Buy | $30 → $36 | $30.92 | +16.43% | 2 | Nov 7, 2024 | |
| PINC Premier | Maintains: Hold | $19 → $21 | $22.23 | -5.53% | 11 | Nov 6, 2024 | |
| AHCO AdaptHealth | Maintains: Buy | $14 → $13 | $9.72 | +33.74% | 6 | Nov 6, 2024 | |
| HSTM HealthStream | Maintains: Hold | $28 → $29 | $31.30 | -7.35% | 5 | Oct 23, 2024 | |
| ACCD Accolade | Maintains: Buy | $13 → $7 | $3.56 | +96.63% | 8 | Oct 9, 2024 | |
| PHR Phreesia | Maintains: Buy | $34 | $18.52 | +83.59% | 8 | Sep 5, 2024 | |
| QIPT Quipt Home Medical | Maintains: Buy | $8 → $6 | $2.42 | +147.93% | 3 | Aug 16, 2024 | |
| TDOC Teladoc Health | Maintains: Buy | $25 → $17 | $9.00 | +88.89% | 15 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $117 → $121 | $127.54 | -5.13% | 3 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 | $7.36 | +49.46% | 6 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $26 | $20.79 | +25.06% | 7 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $41 | $11.31 | +262.51% | 10 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $4.10 | +21.95% | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $3.35 | -10.45% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $1,170 → $225 | $1.83 | +12,195.08% | 6 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $21.88 | +9.69% | 3 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $79 → $95 | $80.53 | +17.97% | 9 | Apr 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $19 → $18 | $51.60 | -65.60% | 4 | Dec 20, 2018 |
Progyny
Nov 13, 2024
Maintains: Hold
Price Target: $18 → $17
Current: $13.98
Upside: +21.60%
Doximity
Nov 13, 2024
Downgrades: Hold
Price Target: $40 → $60
Current: $49.90
Upside: +20.24%
Waystar Holding
Nov 7, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $30.92
Upside: +16.43%
Premier
Nov 6, 2024
Maintains: Hold
Price Target: $19 → $21
Current: $22.23
Upside: -5.53%
AdaptHealth
Nov 6, 2024
Maintains: Buy
Price Target: $14 → $13
Current: $9.72
Upside: +33.74%
HealthStream
Oct 23, 2024
Maintains: Hold
Price Target: $28 → $29
Current: $31.30
Upside: -7.35%
Accolade
Oct 9, 2024
Maintains: Buy
Price Target: $13 → $7
Current: $3.56
Upside: +96.63%
Phreesia
Sep 5, 2024
Maintains: Buy
Price Target: $34
Current: $18.52
Upside: +83.59%
Quipt Home Medical
Aug 16, 2024
Maintains: Buy
Price Target: $8 → $6
Current: $2.42
Upside: +147.93%
Teladoc Health
Aug 1, 2024
Maintains: Buy
Price Target: $25 → $17
Current: $9.00
Upside: +88.89%
Jul 31, 2024
Maintains: Neutral
Price Target: $117 → $121
Current: $127.54
Upside: -5.13%
May 21, 2024
Maintains: Buy
Price Target: $11
Current: $7.36
Upside: +49.46%
May 10, 2024
Maintains: Buy
Price Target: $37 → $26
Current: $20.79
Upside: +25.06%
May 10, 2024
Maintains: Buy
Price Target: $44 → $41
Current: $11.31
Upside: +262.51%
May 9, 2024
Maintains: Buy
Price Target: $9 → $5
Current: $4.10
Upside: +21.95%
Mar 6, 2023
Maintains: Buy
Price Target: $4 → $3
Current: $3.35
Upside: -10.45%
Mar 9, 2022
Maintains: Hold
Price Target: $1,170 → $225
Current: $1.83
Upside: +12,195.08%
Aug 4, 2021
Maintains: Buy
Price Target: $22 → $24
Current: $21.88
Upside: +9.69%
Apr 22, 2021
Maintains: Hold
Price Target: $79 → $95
Current: $80.53
Upside: +17.97%
Dec 20, 2018
Downgrades: Hold
Price Target: $19 → $18
Current: $51.60
Upside: -65.60%